<DOC>
	<DOCNO>NCT00535912</DOCNO>
	<brief_summary>GOELAMS LLC98 prospective randomize trial compare previously untreated B C Binet stag B-CLL intent treat basis two strategy . Conventional chemotherapy consist six monthly course CHOP , follow 6 CHOP course every 3 month case response . Experimental arm consist high dose therapy autologous CD34+ purify progenitor cell support , use consolidation Complete Remission Very Good Partial Response obtain 3 monthly course CHOP , follow 3 6 monthly-courses fludarabine case insufficient response .</brief_summary>
	<brief_title>Phase III Study Treatment CLL B C</brief_title>
	<detailed_description>The aim prospective randomize GOELAMS LLC 98 trial report compare two therapeutic strategy previously untreated B C Binet stag B-CLL patient less 60 year old . Conventional chemotherapy ( Arm A ) consist six monthly course CHOP , i.e . vincristin IV 1 mg/m2 day 1 , doxorubicin IV 25 mg/m2 day 1 , cyclophosphamide ( Cy ) 300 mg/m2 prednisone 40 mg/m2 give orally day 1 day 5 , follow 6 CHOP course every 3 month case response . Fludarabine ( 25 mg/m2 /d IV 5 consecutive day ) use case non response ( stable disease progression ) 3 CHOP course . This conventional therapy compare high dose therapy autologous CD34+ purify progenitor cell support ( Arm B ) , use consolidation Complete Remission ( CR ) Very Good Partial Response ( VGPR , define &gt; 50 % tumoral response bone marrow lymphocyte infiltration &lt; 30 % ) obtain 3 monthly course CHOP . In absence CR VGPR , 3 6 monthly-courses fludarabine perform mobilization Cy 4 g/m2 + G-CSF administration . The condition regimen include TBI 12 Gy Cy 60 mg /kg /d 2 day .</detailed_description>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<criteria>CLL Lymphocitis &gt; 15.10 9/L BCLL stage B C Patients &gt; 18 year old &lt; 60 year old No previous treatment CLL ECOG performance status &lt; 2 Good cardiac function Patient 's write informed consent BCLL stage A Age &gt; 60 year old previous treatment CLL ECOG performance status &gt; 2 Cardiac pneumo Insufficency hepatic renal Insufficency Seropositivity HIV Previous malignancy Fertile male female patient wish use effective method contraception Any coexist medical psychological condition would preclude participation require study procedure NOt sign Patient 's informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>CLL</keyword>
</DOC>